For the 300,000 Americans living with the immune disease scleroderma, better treatments can't come soon enough. The rare and ...

Using skin and blood samples from scleroderma patients, the team grew lab-based skin: pinkish, pancake-like, little disks of ...

Researchers have developed a microneedle patch that can help capture cancer biomarkers in the top-most layer of skin, ...

Genvira Biosciences Inc. ("Genvira"), a Canadian innovator in next-generation viral vectors, Labskin Limited ("Labskin"), a leader in 3D in vitro human skin models, and the National Research Council ...

The Tissue Engineered Skin Substitute Market is projected to be worth USD 2.4 billion in 2024. The market is anticipated to reach USD 3.5 billion by 2034. The market is further expected to surge at a ...

Pal-GHK Peptide and Tissue Engineering The alleged regenerative characteristics of Pal-GHK are not limited to study in dermatology; rather, they are theorized to be potentially relevant in a wider ...

10:33 – Preparing for market access of denovoSkin™. 12:00 – Identifying new opportunities in regenerative medicine, based on personal experience. 13:37 – Predicting the future of skin engineering ...

The evolution of 3D printing for tissue engineering has given rise to a new technology known as bioprinting, defined as " the use of material transfer processes for patterning and assembling ...